SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-140553
Filing Date
2021-11-17
Accepted
2021-11-17 16:05:51
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132965d1_8k.htm   iXBRL 8-K 22426
2 EXHIBIT 99.1 tm2132965d1_ex99-1.htm EX-99.1 77151
6 GRAPHIC tm2132965d1_ex99-1img01.jpg GRAPHIC 8476
  Complete submission text file 0001104659-21-140553.txt   292421

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acur-20211115.xsd EX-101.SCH 3195
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20211115_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20211115_pre.xml EX-101.PRE 22717
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2132965d1_8k_htm.xml XML 3506
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 211420650
SIC: 2834 Pharmaceutical Preparations